IGF2BP2 can function as a post-transcriptional regulator of mRNA localization, stability and translation, and its dysregulated expression is usually associated with various types of cancer, such as colorectal, breast, pancreatic and non-small cell lung cancer [20–23]. Here, IGF2BP2 is linked to cancer.